Needham & Company LLC Reaffirms “Hold” Rating for Cogent Biosciences (NASDAQ:COGT)
Needham & Company LLC reaffirmed their hold rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a research report report published on Wednesday,Benzinga reports. A number of other brokerages also recently issued reports on COGT. Wedbush reaffirmed a “neutral” rating and issued a $11.00 price objective on shares of Cogent Biosciences in a […]
Needham & Company LLC reaffirmed their hold rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a research report report published on Wednesday,Benzinga reports. A number of other brokerages also recently issued reports on COGT. Wedbush reaffirmed a “neutral” rating and issued a $11.00 price objective on shares of Cogent Biosciences in a […]
